Skip to main content
ORTHOCELL LIMITED logo

ORTHOCELL LIMITED — Investor Relations & Filings

Ticker · OCC ISIN · AU000000OCC6 ASX Manufacturing
Filings indexed 780 across all filing types
Latest filing 2026-03-30 Regulatory Filings
Country AU Australia
Listing ASX OCC

About ORTHOCELL LIMITED

https://orthocell.com/

Orthocell Limited is a regenerative medicine company focused on the development and commercialization of innovative technologies for the repair and regeneration of human soft tissue. The company’s core product portfolio includes the CelGro platform, a naturally derived collagen medical device designed to facilitate tissue repair and reconstruction in applications such as dental bone and soft tissue regeneration, nerve repair, and tendon repair. Orthocell also specializes in advanced cellular therapies, notably Ortho-ATI (Autologous Tenocyte Implantation) for treating chronic tendon injuries and Ortho-ACI (Autologous Chondrocyte Implantation) for cartilage repair. These therapies utilize a patient's own cells to restore function and structure to damaged tissues. The company aims to provide restorative solutions that improve clinical outcomes and offer alternatives to traditional surgical interventions.

Recent filings

Filing Released Lang Actions
Orthocell Investor Presentation - Broker Meets Biotech 26 pages 2.4MB
Regulatory Filings
2026-03-30 English
Remplir Used in 23 Surgeries in Ukrainian soldiers 3 pages 176.5KB
Regulatory Filings
2026-03-17 English
Notification regarding unquoted securities - OCC 10 pages 27.2KB
Regulatory Filings
2026-03-15 English
Notification of cessation of securities - OCC 5 pages 16.3KB
Regulatory Filings
2026-03-15 English
Orthocell Appoints UK Distributor for Remplir 3 pages 666.8KB
Regulatory Filings
2026-03-09 English
Appendix 3Y - John Van Der Wielen 2 pages 220.0KB
Regulatory Filings
2026-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.